Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis.
Saved in:
| Title: | Editorial expression of concern: Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis. |
|---|---|
| Authors: | AlOmar S; Department of Clinical Laboratory Sciences, King Saud University, Prince Turki Ibn Abdulaziz Al Awwal Rd, Riyadh, 12371, Saudi Arabia. Salomar1@ksu.edu.sa.; School of Pharmacy, University of Reading, Reading, UK. Salomar1@ksu.edu.sa., Mitchell JL; Cardiovascular Sciences, University of Birmingham, Birmingham, UK., AlZahrani E; School of Pharmacy, University of Reading, Reading, UK. |
| Source: | Thrombosis journal [Thromb J] 2024 Dec 05; Vol. 22 (1), pp. 108. Date of Electronic Publication: 2024 Dec 05. |
| Publication Type: | Journal Article; Expression of Concern |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101170542 Publication Model: Electronic Cited Medium: Print ISSN: 1477-9560 (Print) Linking ISSN: 14779560 NLM ISO Abbreviation: Thromb J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-9560 |
|---|---|
| DOI: | 10.1186/s12959-024-00679-4 |
